Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon May 08, 2018 11:28am
65 Views
Post# 27997692

2018 Clinical Practice Guidelines ...

2018 Clinical Practice Guidelines ...Looks like the issue here in Canada is not Telemedicine or Fundus Cameras ...but more about fighting the disease after you get it... instead of a pre emptive strike against early stage DR... using an AI platform like CARA ...there is nothing like knowing ahead of time... a wake up l ...just like high blood pressure ...things can be managed or reversed  ...this is from 2018 guideline for DR below no mention of AI being used ...

Telemedicine programs relying on fundus photography are widely used in Canada and internationally for the identication and triage of people with diabetic retinopathy.This has been greatly facilitated by the advent of high-resolution ultra-wide eld imaging

https://guidelines.diabetes.ca/docs/cpg/Ch30-Retinopathy.pdf

Wake up Canada time to support AI BY ACTUALLY USING IT ...

Later...
Bob
Bullboard Posts